MHRA Updated Guidance on Managing Clinical Trials During Coronavirus (COVID-19)
On 16 March 2021 the UK MHRA updated the guidance on managing clinical trials during COVID-19.
Read more online Read
EMA Updated the Pharmacovigilance System Manual
On 16 March 2021 the EMA updated the pharmacovigilance system manual version 1.3.
Read the pdf Read
Biocompatibility Assessment Resource Center
On 18 March 2021 the FDA launched a biocompatibility assessment resource center for medical devices.
Read more online Read
EMA Updated the Clinical Trials Information System’s Training Programme
On 16 March 2021 the EMA announced the updates of the clinical trials information system’s training programme.
Read more online Read
FDA’s Ongoing Use of Inspectional Tools for Ensuring Access to Safe, Quality Food and Medical Products During the COVID-19 Pandemic
On 18 March 2021 the FDA published insights from its leadership and experts into the FDA’s approach to foreign and domestic inspections.
Read more online Read
Copyright Widler & Schiemann AG 2020. All Rights Reserved. /